Corcept Therapeutics
CORT
CORT
284 hedge funds and large institutions have $2.9B invested in Corcept Therapeutics in 2024 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 103 increasing their positions, 113 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
0% less funds holding
Funds holding: 285 → 284 (-1)
9% less repeat investments, than reductions
Existing positions increased: 103 | Existing positions reduced: 113
4.71% less ownership
Funds ownership: 90.45% → 85.74% (-4.7%)
Holders
284
Holding in Top 10
5
Calls
$47.4M
Puts
$36.1M
Top Buyers
| 1 | +$17M | |
| 2 | +$7.88M | |
| 3 | +$5.88M | |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
+$5.78M |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$5.65M |
Top Sellers
| 1 | -$21.7M | |
| 2 | -$16.2M | |
| 3 | -$13.8M | |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
-$10.3M |
| 5 |
BlackRock
New York
|
-$9.32M |